首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:International journal of clinical pharmacology and therapeutics

缩写:INT J CLIN PHARM TH

ISSN:0946-1965

e-ISSN:

IF/分区:0.9/Q4

文章目录 更多期刊信息

共收录本刊相关文章索引3351
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Padmamalini Baskaran,Mohammed Aldhaeefi,Anahita Asaadi et al. Padmamalini Baskaran et al.
Background: Black patients experience a disproportionately high incidence of heart failure with reduced ejection fraction (HFrEF), where vasodilators serve as a key therapeutic strategy. ...
Bo Gu,Bing Lv,Jia Tang Bo Gu
Objective: Voclosporin, a novel calcineurin inhibitor (CNI), was FDA-approved in 2021 for treating lupus nephritis (LN). However, post-marketing studies and reports on adverse events (AEs) associated with voclosporin rema...
Aneta Drndarević,Ivana Draganov,Milena Kovačević et al. Aneta Drndarević et al.
Introduction: Drug-drug interactions (DDIs) have been associated with adverse drug reactions (ADRs) which can cause hospitalization. The aim of this study was to associate potential DDIs (pDDIs) with potential ADRs upon a...
Xiaohua Chou,Qian Zhang,Yuanqin Li et al. Xiaohua Chou et al.
Aims: To explore the association of epithelial-mesenchymal transition (EMT)-related biomarkers with an increase in disease severity/progression leading to readmission with acute exacerbation of chronic obstructive pulmona...
Murong Xu,Li Xia,Rong Xiao et al. Murong Xu et al.
Background: Exogenous insulin antibody syndrome (EIAS) is a rare allergic reaction triggered by exogenous insulin. It typically manifests as recurrent hypoglycemia during insulin use. In some cases, patients may also expe...
Le Li,Lifang Yang,Guanglei Xu et al. Le Li et al.
A patient with advanced small cell lung cancer presented with systemic skin pigmentation, a rare and severe skin adverse reaction during treatment with osimertinib. Osimertinib-induced hyperpigmentation is rarely reported, According to the ...